Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Carcinoma and LAG3[original query] |
---|
The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma. Oncoimmunology 2017 6 (8): e1338996. Matsushita Hirokazu, Hasegawa Kosei, Oda Katsutoshi, Yamamoto Shogo, Nishijima Akira, Imai Yuichi, Asada Kayo, Ikeda Yuji, Karasaki Takahiro, Fujiwara Keiichi, Aburatani Hiroyuki, Kakimi Kazuhi |
Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non-Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 May . Higgs Brandon W, Morehouse Christopher A, Streicher Katie, Brohawn Philip Z, Pilataxi Fernanda, Gupta Ashok, Ranade Koustu |
PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients. Frontiers in oncology 2019 12 9 1334. Minichsdorfer Christoph, Oberndorfer Felicitas, Krall Christoph, Kornek Gabriela, Müllauer Leonhard, Wagner Christina, Fuereder Thorst |
Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas. Cancer immunology, immunotherapy : CII 2020 4 69 (7): 1363-1373. Arolt Christoph, Meyer Moritz, Ruesseler Vanessa, Nachtsheim Lisa, Wuerdemann Nora, Dreyer Thomas, Gattenlöhner Stefan, Wittekindt Claus, Buettner Reinhard, Quaas Alexander, Klussmann Jens Pet |
An immune-inflamed tumor microenvironment as defined by CD8 score is associated with favorable oncologic outcomes in hepatocellular carcinoma independent of measures of tumor mutational burden. American journal of cancer research 2022 12 (7): 3099-3110. Cherkassky Leonid, Oshi Masanori, Abdelfatah Eihab, Wu Rongrong, Takabe Yamato, Yan Li, Endo Itaru, Takabe Kazua |
Immune-related risk prognostic model for clear cell renal cell carcinoma: Implications for immunotherapy. Medicine 2023 9 102 (34): e34786. Ronghui Chen, Jun Wu, Shan Liu, Yefeng Sun, Guozhi Liu, Lin Zhang, Qing Yu, Juan Xu, Lingxin Me |
Evaluation of the possible association of PDCD-1 and LAG3 gene polymorphisms with hepatocellular carcinoma risk. BMC medical genomics 2023 5 16 (1): 92. Jiankai Wei, Zhangxiu Liao, Ying Tao, Shuaiting L |
Development and validation of metabolic models for predicting survival and immune status of hepatocellular carcinoma patients. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2023 5 . Xueying Li, Mengli Gu, Qiying Hu, Yihui Weng, Xianlei C |
Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis. Frontiers in immunology 2023 11 14 1238312. Youwei Yue, Xinyi Cai, Changhao Lu, Leonardo Antonio Sechi, Paolo Solla, Shensuo |
Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients. Journal of gastrointestinal oncology 2023 1 13 (6): 3135-3153. Yu Zeyan, Vyungura Olivier, Zhao Yinno |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: